Stem cell therapy for cardiac disease

Congenital heart disease occurs in 1% of liveborn infants, making it the most common birth defect worldwide. Many of these children develop heart failure. In addition, both genetic and acquired forms of dilated cardiomyopathy are a significant source of heart failure in the pediatric population. Heart failure occurs when the myocardium is unable to meet the body’s metabolic demands. Unlike some organs, the heart has limited, if any, capacity for repair after injury. Heart transplantation remains the ultimate approach to treating heart failure, but this is costly and excludes patients who are poor candidates for transplantation given their comorbidities, or for whom a donor organ is unavailable. Stem cell therapy represents the first realistic strategy for reversing the effects of what has until now been considered terminal heart damage. We will discuss potential sources of cardiac-specific stem cells, including mesenchymal, resident cardiac, embryonic, and induced pluripotent stem cells. We will consider efforts to enhance cardiac stem cell engraftment and survival in damaged myocardium, the incorporation of cardiac stem cells into tissue patches, and techniques for creating bioartificial myocardial tissue as well as whole organs. Finally, we will review progress being made in assessing functional improvement in animals and humans after cellular transplant.

[1]  E. Marbán,et al.  Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.

[2]  Clotilde Castaldo,et al.  Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[4]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[5]  Joshua M Hare,et al.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[6]  K. Swedberg,et al.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.

[7]  N. Bursac,et al.  Implantation of Mouse Embryonic Stem Cell-Derived Cardiac Progenitor Cells Preserves Function of Infarcted Murine Hearts , 2010, PloS one.

[8]  P. Anversa,et al.  Chimerism of the transplanted heart. , 2002, The New England journal of medicine.

[9]  Z. Darżynkiewicz,et al.  Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[11]  E. Marbán,et al.  Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. , 2011, Journal of the American College of Cardiology.

[12]  Fumito Ichinose,et al.  Quantitative Assessment of Regional Myocardial Function in Mice by Tissue Doppler Imaging: Comparison With Hemodynamics and Sonomicrometry , 2005, Circulation.

[13]  A. McCulloch,et al.  Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes , 2009, PloS one.

[14]  Benoit G. Bruneau,et al.  Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors , 2009, Nature.

[15]  L. Gepstein,et al.  Identification and selection of cardiomyocytes during human embryonic stem cell differentiation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  M. Franklin,et al.  Cardiomyocyte DNA synthesis and binucleation during murine development. , 1996, The American journal of physiology.

[17]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Shulamit Levenberg,et al.  Transplantation of a tissue-engineered human vascularized cardiac muscle. , 2010, Tissue engineering. Part A.

[19]  Ido Perlman,et al.  Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes , 2004, The Journal of physiology.

[20]  P. Anversa,et al.  Cardiac regeneration. , 2006, Journal of the American College of Cardiology.

[21]  Milica Radisic,et al.  Electrical stimulation systems for cardiac tissue engineering , 2009, Nature Protocols.

[22]  Tetsuo Sasano,et al.  Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy , 2009, Circulation.

[23]  F. Mouquet,et al.  CD31− but Not CD31+ Cardiac Side Population Cells Exhibit Functional Cardiomyogenic Differentiation , 2005, Circulation research.

[24]  Daniel J Garry,et al.  Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. , 2004, Developmental biology.

[25]  Steven B. Bradfute,et al.  Cardiac Muscle Plasticity in Adult and Embryo by Heart‐Derived Progenitor Cells , 2004, Annals of the New York Academy of Sciences.

[26]  O. Yabut,et al.  The promise of human embryonic stem cells in aging-associated diseases , 2011, Aging.

[27]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[28]  Rona Shofti,et al.  Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.

[29]  L. Sharples,et al.  Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching , 2005, The Lancet.

[30]  Steven P Jones,et al.  Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes: Insights Into the Development of Cell-Based Pacemakers , 2005, Circulation.

[31]  W. Stanford,et al.  Concise Review: Stem Cell Antigen‐1: Expression, Function, and Enigma , 2007, Stem cells.

[32]  Milica Radisic,et al.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Boyle,et al.  Sca-1+ Cardiosphere-Derived Cells Are Enriched for Isl1-Expressing Cardiac Precursors and Improve Cardiac Function after Myocardial Injury , 2012, PloS one.

[34]  L. Gepstein,et al.  In Vivo Assessment of the Electrophysiological Integration and Arrhythmogenic Risk of Myocardial Cell Transplantation Strategies , 2010, Stem cells.

[35]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[36]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[37]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[38]  H. S. Bernstein,et al.  Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. , 2010, Cytotherapy.

[39]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[40]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[41]  T. Bartosh,et al.  3D‐model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress , 2008, Journal of cellular biochemistry.

[42]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[43]  P. Doevendans,et al.  Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. , 2007, Stem cell research.

[44]  H. Bernstein,et al.  Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. , 2010, Regenerative medicine.

[45]  E. Marbán,et al.  Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue , 2009, PloS one.

[46]  M. Rubart,et al.  Lineage Tracing of Cardiac Explant Derived Cells , 2008, PloS one.

[47]  H. Matsubara,et al.  Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.

[48]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[49]  A. From,et al.  The Role of the Sca‐1+/CD31− Cardiac Progenitor Cell Population in Postinfarction Left Ventricular Remodeling , 2006, Stem cells.

[50]  Tal Dvir,et al.  Prevascularization of cardiac patch on the omentum improves its therapeutic outcome , 2009, Proceedings of the National Academy of Sciences.

[51]  H. S. Bernstein,et al.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition. , 2012, Cytotherapy.

[52]  N. Benvenisty,et al.  Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells , 2006, Stem cells.

[53]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[54]  Michael D. Schneider,et al.  Telomere attrition and Chk2 activation in human heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Fiumana,et al.  Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function , 2008, Circulation research.

[56]  C. Mummery,et al.  Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. , 2008, Differentiation; research in biological diversity.

[57]  Rene Spijker,et al.  Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells , 2003, Circulation.

[58]  Tal Dvir,et al.  Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. , 2007, Tissue engineering.

[59]  C. Henrikson,et al.  Antiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation , 2005, Circulation research.

[60]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[61]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[62]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.

[63]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[64]  Carissa Ritner,et al.  High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons. , 2011, Stem cells and development.

[65]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[66]  E. Olson,et al.  Transient Regenerative Potential of the Neonatal Mouse Heart , 2011, Science.

[67]  S. Gerecht,et al.  Human embryonic stem cell transplantation to repair the infarcted myocardium , 2007, Heart.

[68]  S. Sheikh,et al.  Murine “Cardiospheres” Are Not a Source of Stem Cells with Cardiomyogenic Potential , 2009, Stem cells.

[69]  Mudit Gupta,et al.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. , 2011, Cell stem cell.

[70]  Carissa Ritner,et al.  miR-125b Promotes Early Germ Layer Specification through Lin28/let-7d and Preferential Differentiation of Mesoderm in Human Embryonic Stem Cells , 2012, PloS one.

[71]  J. Olgin,et al.  Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. , 2004, American journal of physiology. Heart and circulatory physiology.

[72]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[73]  Katriina Aalto-Setälä,et al.  Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype , 2010, Experimental biology and medicine.

[74]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[75]  K. Hensen,et al.  Cardiac stem cells in the real world. , 2008, The Journal of thoracic and cardiovascular surgery.

[76]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[77]  Joshua M Hare,et al.  Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. , 2006, Journal of the American College of Cardiology.

[78]  Fei Ye,et al.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. , 2004, The American journal of cardiology.

[79]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[80]  A. Boyle,et al.  Mesenchymal stem cell therapy for cardiac repair. , 2010, Methods in molecular biology.

[81]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[82]  C. Bearzi,et al.  Human cardiac stem cells , 2005, Proceedings of the National Academy of Sciences.

[83]  R. Yeh,et al.  MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. , 2008, Cell stem cell.

[84]  C. Mummery,et al.  Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. , 2008, Differentiation; research in biological diversity.

[85]  Pauline Chu,et al.  Imaging survival and function of transplanted cardiac resident stem cells. , 2009, Journal of the American College of Cardiology.

[86]  W. Baumgartner,et al.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.

[87]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[88]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[89]  D. Torella,et al.  Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[90]  OrenCaspi,et al.  Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells , 2007 .

[91]  Jeffrey Robbins,et al.  Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury , 2007, Nature Medicine.

[92]  M. Radisic,et al.  Pulsatile perfusion bioreactor for cardiac tissue engineering , 2008, Biotechnology progress.

[93]  古田 晃.  Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo , 2007 .

[94]  A. Keating,et al.  Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes? , 2008, Circulation research.

[95]  Jeremy J Mao,et al.  Mesenchymal stem cells: isolation and therapeutics. , 2004, Stem cells and development.

[96]  F. Mouquet,et al.  Role of the ATP-Binding Cassette Transporter Abcg2 in the Phenotype and Function of Cardiac Side Population Cells , 2008, Circulation research.

[97]  Andreas Hess,et al.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.

[98]  A. Colman,et al.  Highly enriched cardiomyocytes from human embryonic stem cells. , 2008, Cytotherapy.

[99]  Chunhui Xu,et al.  Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells , 2002, Circulation research.

[100]  D. Erle,et al.  An Engineered Cardiac Reporter Cell Line Identifies Human Embryonic Stem Cell-Derived Myocardial Precursors , 2011, PloS one.

[101]  Chris Denning,et al.  Transgenic enrichment of cardiomyocytes from human embryonic stem cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[102]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[103]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[104]  K. Tokunaga,et al.  Human Leukocyte Antigen Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy , 2007, Stem cells.

[105]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.